Panel on Arteriosclerosis*
WILLIAM DOCK, MODERATOR

Dr. William Dock (professor of
medicine, Downstate Medical Center,
State University of New York): One
of the points I should like to make, is
that smoking acts on the circulation
only by the absorption of nicotine. It
has nothing to do with the smoke. In
other words, to get on the wrong side
of the cook-out fire will not increase
much the risk of coronary disease,
although it might give you bronchial
carcinoma after 50 or 100 years. Nicotine acts much as though the individual who smokes a cigarette or gets a
good chew of tobacco had been given
a good intravenous infusion of epinephrine or norepinephrine. The free
fatty acid goes up, the blood pressure
goes up, and the stroke volume goes
up. The stresses produced on the circulation by nicotine are exactly like
those produced by catecholamines.
While you can change to chewing or
switch to a pipe to get rid of obstructive emphysema, the effects of nicotine
on the coronary vessels will be the
same no matter how you absorb it.
We assume the effects of smoking on
coronary disease are what you'd expect if the patient were getting infusions of epinephrine during the day, at
regular and very frequent intervals.
Caffeine also apparently acts in somewhat the same way. Of course, CocaCola does, too. Any of these things
can accelerate atherosclerosis some. As
the people in Cincinnati have reported
repeatedly, and as the nicotine symposium held in New York at the National Academy of Sciences strongly
emphasized, chewers of tobacco have
much worse vascular disease in the
legs and much more coronary disease,
age corrected, than two-pack-a-day
cigarette smokers. Of course, they get
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the most nicotine for their money. If
you want nicotine, and they want nicotine, there is a price to pay when you
are on the North American diet. On
the other hand, presumably, a tobacco
smoker in North China runs no additional risk of coronary disease, because he runs no risk to begin with.
Dr. William Hollander (associate
professor of medicine, Boston University School of Medicine): Dr. Dock,
could I perhaps comment on the effect
of catecholamines on the metabolism
of the arterial wall? We have some
observations regarding the effects of
norephinephrine on our incubated arterial tissue, including atherosclerotic
tissue. What we have been finding is
that, as you have indicated, catecholamines stimulate the lipoprotein lipase
activity in atherosclerotic tissue. Consequently, the triglyceride content falls
off very strikingly within a period of
four hours. You can actually measure
a drop in the lipid content in these
arterial walls.
What about Buerger's disease? This
disease can be aggravated by smoking.
I do not know what the in vivo effects
of norepinephrine are in Buerger's.
And anyway, in Boston the pathologists say that there is no difference between Buerger's disease and ordinary
atherosclerotic disease of the legs.
Sir George W . Pickering (regius
professor of medicine, Oxford University): Could I disagree with that? I
have been concerned with people with
vascular disease of the legs ever since
I went to work with Sir Thomas Lewis.
These two diseases are quite different
clinically, whatever they are like histologically. Buerger's disease is a disease
of young men which is practically unknown in females, and it stops like that
if you stop smoking. The influence of
tobacco on Buerger's disease is, I
think, 100% .
Dr. Dock: Early Buerger's arteries
are full of lipid only with the North

American diet of the present time.
When you get syphilis, or when you
get Buerger's disease, you get atherosclerosis on top of it because of our
diet. In the regions where people don't
get highly fatty diets you can see pure
Buerger's, and you can see pure syphilitic aortitis without atheroma.
Well, we don't want any of our patients to get syphilis and we hope they
all will stop smoking. The smoking
influence is so clear-cut in statistical
studies that it is a tragedy that it is
easier for a patient to have blood
drawn every week to see how his prothrombin is doing, and take Coumadin
pills, than it is for him to stop buying
tobacco. Tobacco is an extremely addicting drug, probably as addicting as
morphine. And the physiological damage done by tobacco or nicotine is
certainly much worse than that done
by morphine. If you don't smoke
opium, you don't get obstructive emphysema from it. If you take morphine
in little pills, it makes you feel good
just the way smoking does, but it does
not produce the catecholamine effect,
and there is no evidence that it produces arteriosclerosis or even aggravates it. So, we are hoping to get the
Narcotic Act repealed! Everybody on
the panel but me and Dr. Stamler, I
think, are two-pack-a-day or ninepipe-a-day smokers. You see how hard
it is to stop the addiction. Dr. Pickering and I knew three full professors of
medicine in leading American universities who died of obstructive emphysema. Not one of these men could cut
down his smoking though he knew he
was headed for the boneyard. One of
them used to sneak into his garret and
smoke so his wife could not catch him,
and this was after he had been in the
hospital and in a helium tent. So, we
have agreed on the panel that you cannot give up smoking, and most of us
agree, I think, that patients cannot be
persuaded to stay on diets. Dr. Stam-
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ler, can they be persuaded?
Dr. Jeremiah Stamler (director of
the heart disease control program,
City of Chicago Board of Health): The
question is not whether people can be
persuaded to stay on a diet. I think the
question is whether a population can
change its eating habits sufficiently to
alter the pattern of a disease. If what
we are really talking about is meaningful and important, it has a whole lot of
sociological consequences which come
into play beginning with the earliest
period of habit formation, in the time
of weaning. I was talking with Dr.
William Harlan about what happens to
young men in America. They are very
active in athletics, they develop the
training table or the basic training pattern of eating. Then they stop physical
activity when they cease to be active in
athletics or leave the armed forces, but
they keep on eating the same way. Or,
even worse, they fall into the hands of
a wonderful, lovely little girl who
wants to show that she learned the
right things from Mamma about cooking.
Dr. Dock: Now, Dr. Pickering, I
think we should give you a chance to
get back into the argument. In the first
place, does your group feel that diet
has any importance whatever in the
pathogenesis of vascular disease?
Prof. Pickering: As August Krogh
once remarked, "Physiological phenomena are so complicated that, if you
argue from more than one step to
another without the control of experiment, you are almost certain to go
wrong." Before I would be prepared
to encourage a mass change of diet, I
would like to have a pilot study to see
that this mass change was doing a certain amount of good. If I remember
rightly, there is a certain well-known
professor of medicine who put himself
on a very rigid low-fat, no cholesterol
diet, and has since had a cholesterol
stone removed from his gall bladder.
Dr. Dock: And you conclude that it
formed after he went on the diet?
Prof. Pickering: Well, he may have
had it before, that is perfectly true.
Dr. Dock: I think that Dr. Pickering
has brought up a very important point.
A man with asymptomatic gall stones
who goes on a diet with vegetable oil
is very likely to have his stones decrease in size to where they can slip

into the cystic or common duct. Then
he will have his first attack of colic
one, two, or three years after he has
cut his cholesterol intake, because the
stones will get smaller and give symptoms. I have had three such patients.
One of them had his gall stones taken
out at Peter Bent Brigham Hospital
after his fifth attack of colic. His first
attack came on about three years after
he changed his diet. Fortunately he
had had his gall bladder visualized
eight years before, and beautiful, big
cholesterol stones had been seen, far
too big to get into his duct.
I think that if you try to starve too
fast, you may run your serum triglycerides up quite high by starvation.
People have their first bout of myocardial infarction just after they have
gone on a marked weight reduction
program. This has been noted over and
over again. There is a great craze now
in parts of the United States for starvation as the way to start a weight reduction program. It can be predicted
that this should up the incidence of
coronary disease in the first three
months after you go on that sort of
program. Whether it will, I don't
know.
I think that physicians who feel, as
Dr. Pickering and his group do, that
the role of diet in vascular disease is
not yet established, should say as much
to their patients. This seems to me to
be perfectly sound, rational management.
On the other hand, Pickering is a
doctor who thinks perhaps Harvey was
right in saying that if animal experiment indicates that the blood circulates, then it may circulate in man. If
you take animal experiment as being
relevant to human physiology and pathology, and you know that dietary
manipulation will produce vascular
disease in chickens, rats, guinea pigs,
rabbits, dogs, hamsters, monkeys, and
pigs, it does become a little awkward
to say, "Well, we don't believe that
animal experiment is relevant to human experience in this particular
field." It is perfectly sound doctrine to
say this, as it was for Dr. Sydenham to
say, "Just because Harvey thought that
blood circulated in a snake or a deer
is no reason to think that blood circulates in man." To me, this is perfectly
sound, rational argument. Sydenham

was the greatest internist of his generation. You can be a great man in
your generation, and it may turn out
that you were right. Or, it may turn
out that you did not take as seriously
as you should have the data that were
available.
Prof. Pickering: Yes, there is a little
difference, though. You will recall that
Krogh said, "If you argue from one set
of data to another without the control
of experiment you are likely to go
wrong." And I believe that there is a
difference between the rabbit and the
human being. The diet that rabbits eat
in experiments is very different from
the diets that they ordinarily eat. And
the lesion which is produced in rabbits
is not quite the same as the lesion
which produces myocardial infarction
in men. And so, I think your reasoning
will not hold up at every point, and
even if it did, man is a different species
from rabbit. I would like to see the
effect of diet demonstrated in man before I am prepared to believe it is effective in controlling vascular disease.
Dr. Dock: Well, this experiment is
under way in the United States at enormous expense at the present time.
Dr. Stamler: Could I just say a word
about this? I didn't get to hear Sir
George, but I have read some of his
writings, and I had the good fortune
to hear the tape of his lecture earlier
in this symposium. I'd like to dismiss
one or two of the arguments which I
don't think are entirely valid, or, if not
dismiss them, at least put them on the
table for rediscussion. The first is the
question of the rabbit as an atypical
species. The second is the matter of
drowning the animals in very high cholesterol, high fat diets. Both of these
were problems in 1948. I do not think
either is much of a problem now for
the following reasons: 1) The disease
has, in fact, been reproduced, with a
lesion remarkably similar to the human lesions, in a wide range of species,
as Dr. Dock said. So the problem that
did confront workers in the 1930's,
that of the ability to reproduce the disease only in the rabbit or guinea pig,
is no longer entirely true. In fact, quite
the opposite is true. We have the dog,
rat, chicken, rabbit, and a variety of
monkeys. The monkey experiments
have been done using diets similar to
the human diet, in fact, feeding human
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foods in periods that correspond to a
life span equivalent to human beings.
These produced moderate elevations
of the serum cholesterol level in the
200's and 300's, peripheral gangrene,
myocardial infarction, and cerebral infarction.
On the question of experiment in
man, I would like to add a word to
that. As practicing doctors, I think
that the profession has a very difficult
problem. Let's face it, these studies in
the population may not come off. If
they do come off, they will take a decade at least to get an answer. And
what does one do in the interim, wait
for the results of the experiment, and
say, "Well, we're not sure." That's OK,
but every physician who makes that
decision has to accept the corollary of
it, and even has to tell his patient of
the corollary. " If you are a high risk,
middle-aged American man, I have
very little to offer you while I'm waiting for the purity of a scientific answer." Because, really, we do not have
much to offer aside from our approach
to these risk factors, of which diet,
blood cholesterol, and weight are three
key ones. If we are prepared to accept
that corollary, and transmit it to our
patients, then I say we can wait for
the big experiment, if it ever gets done.
If not, I think we should intervene in
a safe way.
Prof. Pickering: Well, that is what I
think I said. If the doctor, himself,
does not believe in this, he should tell
his patients he does not believe in it.
If they want to go on the diet, he is
glad to direct them. If he does believe
in it, he has got to practice what is
known as the Golden Rule and say, "If
I had your trouble, this is what I would
do . . .. " I think this is the best any of
us can do. The same thing applies to
the use of anticoagulants. If the patient says, "Well, would you take this
yourself?" I have to tell him that I
hate to have my arms stuck every
week, and for a difference in mortality
of 4% as against 5% a year, roughly,
I don't believe I would take all of this
trouble.
Dr. Stamler and I have rather different views about atherosclerosis, I
think. He would include a lot of lesions that I suspect are not the same.
Dr. Stam/er: I include only lesions
with porridge in them-no lipid, no
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atherosclerosis, as far as I am concerned. Patients who have been starved
have fibrous plaques and calcium, but
no demonstrable lipid when they die.
It is true in man that the lipid can disappear so you see only the scar of the
disease. If I had to limit the diagnosis
of syphilitic aortitis to people in whom
I could demonstrate treponemes, I
would be out of luck, because penicillin has killed the treponemes in all
of my patients. Just as I diagnose
former syphilitic aortitis from sections,
I now diagnose former atherosclerosis
at autopsy in patients who, as a result
of leukemia, say, have lost a great deal
of weight and been markedly undernourished through periods of about
two years before they died. So you can
lose the lipid from plaques, I'm sure.
Furthermore, I believe that lipid is
present in the lesions of adolescence in
larger quantities than it is in the lesions
of men of 40, and is present in larger
quantities in men who die at 40 than
it is in men who die at 70. These are
my own views. This is almost a question of religious experience. Dr. Pickering belongs to one church, and has
had one religious background in this
field . I belong to a different church,
having had different clergymen working on me in my youth. So, I don't expect to convince Professor Pickering
that the lesions I showed in small vessels are related to the lesions that the
same patients had in their coronary arteries, although both of those patients
from whom I showed you sections
were hypertensives with hypercholesterolemia who died of myocardial infarction. They had lesions in small arteries. Dr. Pickering thinks these are
unrelated to the lesions in the coronaries. I cannot see why they might
not be the same lesions.
Prof. Pickering: Well, I think they
are different. Partially because they
look different, and partially because, in
the small arteries, kidney, and in the
retinal arterioles, lesions are much
more closely correlated with the
height of the arterial pressure than is
the disease I was talking about which
produces big nodules in arteries like
the carotid, and ultimately leads to
thrombosis of them.
I will not agree with Dr. Dock that,
because you can see lipid in them both,
they represent the same disease. He
says we belong to different churches. I
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think he does belong to a church. I am
just a plain agnostic.
Dr. William R. Harlan, Jr. (director of clinical research center, Medical College of Virginia): It is much
easier to make long studies of large
series of cases with a drug than it is
with a diet, and I think this may turn
out in the end to be a more profitable
way of shedding light on what the
plasma lipid has to do with arteriosclerosis in man. It will not settle
whether plasma lipid acts by accelerating coagulation, but at least it would
cast some light on whether changing
the lipid levels in the plasma would
improve the prognosis.
We ought to ask Dr. Stamler about
estrogens and the drug androsterone,
which we produce in our bodies-a
very weak androgen but it tends to
lower blood cholesterol. These two
agents can be given to lower plasma
lipid, at least plasma cholesterol levels,
in male patients. Are you still carrying
on estrogen studies?
Dr. Stam/er: In brief, there are three
reports of a controlled nature on the
estrogens in post-myocardial infarction in man. One of them is a British
study by Oliver and Boyd that deals
with 100 patjents up to age 65. Another is an American study that deals
with men of all ages on lower doses
of mixed conjugated equine estrogen.
Oliver and Boyd used ethanyl estradiol.
The third study is by our group in Chicago, using mixed conjugated equine
estrogens in men under 50. In the 100
patients whom they studied, Oliver and
Boyd got completely negative results,
although serum cholesterol levels were
lower. The Los Angeles study with
lower doses of mixed conjugated
equine estrogen is still in progress, but
there are positive results, particularly
in the patients under 50. I think none
of these studies to date permits a cleancut decision on the efficacy of estrogens. I might note that there is a peculiar aspect to the estrogen work;
while ethanyl estradiol consistently
lowers total blood cholesterol level,
mixed conjugated equine estrogens do
not. They shift the lipoprotein pattern,
but they do not consistently lower the
total cholesterol level. They raise the
a - and may lower the /3- proportionately, so that total cholesterol
changes very little. They do, unques-

tionably, convert the a- from a male
level of about 50 or so to a female
level of 250, 300, 350, or greater.
Whether this is efficacious is, of course,
moot.
Dr. Dock: One of the questions is
whether a reduction in blood pressure
will help us have a lower incidence of
cardiovascular disease. I think you believe it will.
Prof. Pickering: No, I don't believe
it will. I think the evidence suggesting
this is bad.
Dr. Dock: You said that in severe
hypertensives, lowering blood pressure
changes the whole course of the disease. If this is true, how can it help
but lower the death rate?
Prof. Pickering: Oh, I thought you
were talking about arteriosclerosis.
Dr. Dock: No, no. In any sort of
vascular disease, will lowering the
blood pressure improve the prognosis?
Prof. Pickering: Well, it depends on
how high the blood pressure is. If the
blood pressure is very high, or if you
get a patient in the malignant phase
before the kidneys are really very severely involved, then I think the evidence is quite clear that you can prolong the expectation of life.
Dr. Dock: But in a patient with a
lower level of blood pressure and with
a myocardial infarct, is it worthwhile
to try to lower the blood pressure?
Prof. Pickering: No, I would not say
that. But I think that I have distinguished what I would regard as established, and what I would regard as a
sufficient degree of probability, so that
I would use it in the treatment of my
patients. I do not regard it as established that diet will reduce the prevalence of myocardial infarction, but instead, I do advise my patients: 1) to
try to regain their youthful figures, 2)
to substitute corn oil for their ordinary
cooking fat, 3) to take as much exercise as they conveniently can, 4) if
their arterial pressure is high, I reduce
it, and 5) if they are under 55 and
male, I put them on anticoagulants,
but I do not ever go very high with
them, because I am afraid of them. I
do not use anticoagulants in patients
with peptic ulcer, gross hypertension,
or liver disease.
Dr. Dock: Well, I think with this
useful advice, perhaps we had better
bring the meeting to a close.
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